These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 2421926)
21. Strain differentiation of polioviruses with monoclonal antibodies. Osterhaus AD; van Wezel AL; Stegmann AJ; van Asten JA; Hazendonk AG Dev Biol Stand; 1984; 57():135-9. PubMed ID: 6098494 [TBL] [Abstract][Full Text] [Related]
22. Monoclonal antibodies against Schistosoma mekongi surface tegumental antigens. Viyanant V; Gajanadana O; Upatham ES; Sobhon P; Kruatrachue M; Ahmed S; Ardseungnoen P Southeast Asian J Trop Med Public Health; 1993 Sep; 24(3):484-8. PubMed ID: 7512753 [TBL] [Abstract][Full Text] [Related]
23. Production of hybrid cell lines secreting monoclonal antibodies against poliovirus Type 2. Guo R; Tang EH; Jiang YQ; Wen YL; Lu FM; Lin JY Chin Med J (Engl); 1983 Sep; 96(9):669-74. PubMed ID: 6317298 [No Abstract] [Full Text] [Related]
24. Detection by monoclonal antibodies of an antigenic determinant critical for poliovirus neutralization present on VP1 and on heat-inactivated virions. Blondel B; Akacem O; Crainic R; Couillin P; Horodniceanu F Virology; 1983 Apr; 126(2):707-10. PubMed ID: 6190311 [TBL] [Abstract][Full Text] [Related]
25. [Monoclonal antibodies against Brunhilde strain of poliovirus type I]. Tang EH; Jian YQ; Wen YL; Lin JY; Guo R Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1984 Apr; 6(2):150-2. PubMed ID: 6100481 [No Abstract] [Full Text] [Related]
26. [Type-specific and strain-specific monoclonal antibody against type 1 poliovirus]. Gu FZ Zhonghua Yi Xue Za Zhi; 1983 Feb; 63(2):69-72. PubMed ID: 6305464 [No Abstract] [Full Text] [Related]
27. [Obtaining of new monoclonal antibodies against human immunoglobulins of class G, suitable for use in diagnostics of infectious diseases]. Halkin OIu; Nikolaienko IV; Raievs'ka HIe; Mykhaĭlenko LP; Kostenko OH; Spivak MIa Mikrobiol Z; 2005; 67(6):40-8. PubMed ID: 16493884 [TBL] [Abstract][Full Text] [Related]
28. Preliminary studies on antigenic variation of poliovirus using neutralizing monoclonal antibodies. Guo R; Tang EH; Wang H; Yang XF; Liu MY; Qin HX; Li QH; Zhuang JY; Liu KM J Gen Virol; 1987 Apr; 68 ( Pt 4)():989-94. PubMed ID: 3033136 [TBL] [Abstract][Full Text] [Related]
29. [Antigenic analysis of 100 strains of poliomyelitis type I virus by monoclonal antibody]. Gu FZ Zhonghua Yu Fang Yi Xue Za Zhi; 1985 Sep; 19(5):265-7. PubMed ID: 3004840 [No Abstract] [Full Text] [Related]
30. Potency test of killed polio vaccines. Statistical analysis of test on chicken and preliminary results in combination with ELISA D-antigen determinations. Larbaigt G; Moulin J; Souvras M; Gibelin N; Beranger G Dev Biol Stand; 1981; 47():113-8. PubMed ID: 6262141 [TBL] [Abstract][Full Text] [Related]
31. Potency of wild-type or sabin trivalent inactivated poliovirus vaccine, by enzyme-linked immunosorbent assay using monoclonal antibiotics specific for each antigenic site. Sawyer LA; Wood D; Ferguson M; Crainic R; Beuvery EC; McInnis J; Albrecht P Biologicals; 1997 Sep; 25(3):299-306. PubMed ID: 9324998 [TBL] [Abstract][Full Text] [Related]
32. Monoclonal antibodies reveal in blocking reactions the antigenicity and antibody response of poliovirus. Uhlig H; Rutter G; Dernick R Dev Biol Stand; 1984; 57():187-91. PubMed ID: 6084610 [TBL] [Abstract][Full Text] [Related]
33. Use of monoclonal antibodies prepared with Sabin vaccine viruses for the characterization of poliovirus strains isolated in Canada. Wachmann B; Henning D; Armstrong R; Boucher DW; Contreras G; Furesz J Dev Biol Stand; 1984; 57():141-9. PubMed ID: 6084605 [TBL] [Abstract][Full Text] [Related]
34. Production and characterization of monoclonal antibodies against different epitopes of Ebola virus antigens. Shahhosseini S; Das D; Qiu X; Feldmann H; Jones SM; Suresh MR J Virol Methods; 2007 Jul; 143(1):29-37. PubMed ID: 17368819 [TBL] [Abstract][Full Text] [Related]
35. Antigen chimaeras of poliovirus as potential new vaccines. Burke KL; Dunn G; Ferguson M; Minor PD; Almond JW Nature; 1988 Mar; 332(6159):81-2. PubMed ID: 2450279 [TBL] [Abstract][Full Text] [Related]
36. Comparisons of poliovirus antigen measurements in vitro and in small animals. von Seefried A; Bryce E; Campbell JB; Chun JH; Laurence GD; Scollard N; Tsai KS Dev Biol Stand; 1981; 47():91-100. PubMed ID: 6262165 [No Abstract] [Full Text] [Related]
37. Application of monoclonal antibodies for the identification of the antigenic site for poliovirus neutralization. Minor PD; Schild GC; Evans D; Ferguson M; Almond J Dev Biol Stand; 1984; 57():171-5. PubMed ID: 6084608 [TBL] [Abstract][Full Text] [Related]
38. Strain analysis and epitope mapping of West Nile virus using monoclonal antibodies. Damle RG; Yeolekar LR; Rao BL Acta Virol; 1998 Dec; 42(6):389-95. PubMed ID: 10358745 [TBL] [Abstract][Full Text] [Related]
39. Improved ELISA test for determination of potency of Inactivated Poliovirus Vaccine (IPV). Rezapkin G; Dragunsky E; Chumakov K Biologicals; 2005 Mar; 33(1):17-27. PubMed ID: 15713553 [TBL] [Abstract][Full Text] [Related]
40. Determination of type 1 poliovirus subtype classes with neutralizing monoclonal antibodies. Crainic R; Couillin P; Cabau N; Boue A; Horodniceanu F Dev Biol Stand; 1981; 50():229-34. PubMed ID: 6176486 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]